The Latest from

• 

  June 9, 2022

  Without the right numbers, investors would never know Peloton is making money

  

  ...Read More

• 

  June 2, 2022

  Pfizer just made its biggest acquisition in years… let’s understand exactly why

  

  ...Read More

• 

  May 26, 2022

  As-reported metrics make Equifax look far less profitable than reality

  

  ...Read More

• 

  May 19, 2022

  As-reported metrics make Lululemon look like just an average company rather than a trendsetter

  

  ...Read More

• 

  May 12, 2022

  GAAP accounting misses that Fiserv is at the heart of the monetary revolution

  

  ...Read More

• 

  May 5, 2022

  For investors looking to ride the cloud storage boom, look to names like NetApp

  

  ...Read More

• 

  April 28, 2022

  Ryan Cohen has moved onto other companies, but his legacy company may be more tarnished than he admits

  

  ...Read More

• 

  April 21, 2022

  AutoZone has reached new highs in 2022…just as we predicted last year

  

  ...Read More

• 

  April 14, 2022

  Cintas Corporation saw a strong performance when the rest of the world shut down

  

  ...Read More

• 

  April 8, 2022

  After an extended hiatus from big investments, Warren Buffett just announced his three biggest deals in years

  

  ...Read More

• 

  April 7, 2022

  How Garmin shifted from a standalone GPS manufacturer to a high-tech specialty business

  

  ...Read More

• 

  March 31, 2022

  Riding the SaaS wave has helped turn PTC around

  

  ...Read More

• 

  March 24, 2022

  The pandemic gave this e-signature company a chance for recovery

  

  ...Read More

• 

  March 17, 2022

  The pandemic was a lifeline for Mattel, but it may be running out

  

  ...Read More

• 

  March 10, 2022

  Whirlpool is ready to ride strong capex tailwinds to profitability

  

  ...Read More

• 

  March 3, 2022

  CarMax is riding the strong tailwinds of the At-Home Revolution

  

  ...Read More

• 

  February 24, 2022

  Workday has turned remote work into a massive profit center

  

  ...Read More

• 

  February 17, 2022

  Johnson Controls turns a construction necessity into an ESG boon

  

  ...Read More

• 

  February 10, 2022

  Zoetis shows pharma for animals is just as valuable as for people

  

  ...Read More

• 

  February 3, 2022

  Amgen’s patent cliff may not have been the end for the biotech giant

  

  ...Read More